Cargando…

Corrigendum to “Reduced Oxidative Stress Contributes to the Lipid Lowering Effects of Isoquercitrin in Free Fatty Acids Induced Hepatocytes”

Detalles Bibliográficos
Autores principales:	Hassan, Waseem, Rongyin, Gao, Daoud, Abdelkader, Ding, Lin, Wang, Lulu, Liu, Jun, Shang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412213/ https://www.ncbi.nlm.nih.gov/pubmed/25969701 http://dx.doi.org/10.1155/2015/383525

Ejemplares similares

Reduced Oxidative Stress Contributes to the Lipid Lowering Effects of Isoquercitrin in Free Fatty Acids Induced Hepatocytes
por: Hassan, Waseem, et al.
Publicado: (2014)

Effect of Isoquercitrin on Free Fatty Acid-Induced Lipid Accumulation in HepG2 Cells
por: Kim, Sou Hyun, et al.
Publicado: (2023)

Corrigendum to “Fatty Acid Profiles of Stipe and Blade from the Norwegian Brown Macroalgae Laminaria Hyperborea with Special Reference to Acyl Glycerides, Polar Lipids, and Free Fatty Acids”
por: Foseid, Lena, et al.
Publicado: (2021)

Corrigendum to “Protective Effects of Simvastatin, a Lipid Lowering Agent, Against Oxidative Damage in Experimental Diabetic Rats”
por: Mohamadin, Ahmed M., et al.
Publicado: (2020)

Corrigendum to “Dietary Lipids in Health and Disease”
por: Amin, Kamal A., et al.
Publicado: (2020)

Comprehensive lipid and metabolite profiling in healthy adults with low and high consumption of fatty fish: a cross-sectional study – CORRIGENDUM
por: Hustad, K. S., et al.
Publicado: (2022)

Corrigendum: Vegetarian diet, food substitution, and nonalcoholic fatty liver
Publicado: (2018)

Corrigendum to “Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases”
por: Kumar, Manoj, et al.
Publicado: (2022)

Corrigendum to “A Rare Presentation of Cardiac Tamponade from Metastatic Urothelial Carcinoma of the Bladder”
por: Palam, Sowmya, et al.
Publicado: (2019)

Corrigendum to “Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease”
por: Masarone, Mario, et al.
Publicado: (2021)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
Publicado: (2023)

Fat Free Weight Prediction in Morbidly Obese Females [Corrigendum]
Publicado: (2022)

Emodin-Induced Autophagy Against Cell Apoptosis Through the PI3K/AKT/mTOR Pathway in Human Hepatocytes [Corrigendum]
Publicado: (2022)

Corrigendum to “Resolving Contributions of Oxygen-Consuming and ROS-Generating Enzymes at the Synapse”
por: Abdel-Rahman, Engy A., et al.
Publicado: (2017)

Corrigendum to: Contribution of histone N‐terminal tails to the structure and stability of nucleosomes
por: Iwasaki, Wakana, et al.
Publicado: (2018)

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction [Corrigendum]
Publicado: (2017)

Corrigendum: Partial second toe pulp free flaps in early childhood
por: Hong, Min Ki, et al.
Publicado: (2021)

Corrigendum to “Prospective Analysis of Lipid Variations in Hyperthyroid Subjects from Lahore, Pakistan”
por: Iqbal, Muhammad Amir, et al.
Publicado: (2022)

Corrigendum: High-throughput, nonperturbing quantification of lipid droplets with digital holographic microscopy
por: Campos, Vasco, et al.
Publicado: (2022)

Corrigendum: Kounis syndrome induced by oral intake of aspirin: case report and literature review
por: Hangouche, Abdelkader Jalil El, et al.
Publicado: (2019)

Corrigendum to “Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp”
por: Mahamid, Mahmud, et al.
Publicado: (2017)

Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy [Corrigendum]
Publicado: (2021)

Corrigendum to “Serglycin‐induced interleukin‐1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts topromote tumour angiogenesis and growth”
Publicado: (2023)

Corrigendum to “Natural Treatment Systems as Sustainable Ecotechnologies for the Developing Countries”
por: Mahmood, Qaisar, et al.
Publicado: (2018)

Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer [Corrigendum]
Publicado: (2023)

Corrigendum to “Gene networks and transcription factor motifs defining the differentiation of human stem cells into hepatocyte-like cells” [J Hepatol 2015;63:934–942]
por: Godoy, Patricio, et al.
Publicado: (2016)

Corrigendum: Influence of head‐up tilt and lower body negative pressure on the internal jugular vein
Publicado: (2022)

Corrigendum
por: Zong, Wubei, et al.
Publicado: (2023)

Corrigendum to “β-Catenin-Dependent Signaling Pathway Contributes to Renal Fibrosis in Hypertensive Rats”
por: Cuevas, Catherina A., et al.
Publicado: (2016)

Corrigendum to “MUTYH Actively Contributes to Microglial Activation and Impaired Neurogenesis in the Pathogenesis of Alzheimer's Disease”
por: Mizuno, Yuri, et al.
Publicado: (2023)

Corrigendum: Les caractéristiques de la population couverte par le régime de l’assurance maladie obligatoire au Maroc
por: Yassine, Amal, et al.
Publicado: (2019)

Corrigendum: Les caractéristiques de la population couverte par le régime de l’assurance maladie obligatoire au Maroc
por: Yassine, Amal, et al.
Publicado: (2019)

Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”
por: Shazly, Gamal A.
Publicado: (2017)

Solid Lipid Nanoparticles for Thermoresponsive Targeting: Evidence from Spectrophotometry, Electrochemical, and Cytotoxicity Studies [Corrigendum]
Publicado: (2021)

Solid Lipid Nanoparticles for Thermoresponsive Targeting: Evidence from Spectrophotometry, Electrochemical, and Cytotoxicity Studies [Corrigendum]
Publicado: (2021)

Corrigendum to “The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease”
por: Lewis, John E., et al.
Publicado: (2020)

Corrigendum to “Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus”
por: Tang, Ruiqi, et al.
Publicado: (2021)

Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study [Corrigendum]
Publicado: (2018)

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
por: Kim, Kyuho, et al.
Publicado: (2022)

Corrigendum to “Effects of an Aqueous Extract of Dangguijagyagsan on Serum Lipid Levels and Blood Flow Improvement in Ovariectomized Rats”
por: Park, In Sil, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c6jtof37skdgbqjf5cq71qr8ct